Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Depreciation & Amortization (IS)EBIATMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsShares IssuedShares RepurchasedShort-Term Debt repayments
Ratios

Ani Pharmaceuticals (ANIP) Shares Outstanding: 2009-2022

Historic Shares Outstanding for Ani Pharmaceuticals (ANIP) over the last 4 years, with Jun 2022 value amounting to $17.6 million.

  • Ani Pharmaceuticals' Shares Outstanding rose 36.96% to $17.6 million in Q2 2022 from the same period last year, while for Jun 2022 it was $17.6 million, marking a year-over-year increase of 36.96%. This contributed to the annual value of $16.9 million for FY2021, which is 36.07% up from last year.
  • Per Ani Pharmaceuticals' latest filing, its Shares Outstanding stood at $17.6 million for Q2 2022, which was up 1.11% from $17.4 million recorded in Q1 2022.
  • Over the past 5 years, Ani Pharmaceuticals' Shares Outstanding peaked at $17.6 million during Q2 2022, and registered a low of $11,730 during Q1 2018.
  • Moreover, its 3-year median value for Shares Outstanding was $12.8 million (2021), whereas its average is $14.0 million.
  • Data for Ani Pharmaceuticals' Shares Outstanding shows a peak YoY soared of 102,406.39% (in 2019) over the last 5 years.
  • Quarterly analysis of 5 years shows Ani Pharmaceuticals' Shares Outstanding stood at $11.9 million in 2018, then climbed by 2.04% to $12.1 million in 2019, then grew by 2.68% to $12.4 million in 2020, then spiked by 36.07% to $16.9 million in 2021, then spiked by 36.96% to $17.6 million in 2022.
  • Its Shares Outstanding stands at $17.6 million for Q2 2022, versus $17.4 million for Q1 2022 and $16.9 million for Q4 2021.